Skip to main content
Rahul Patel, MD, Rheumatology, Irving, TX

RahulKPatelMDFACP, FACR

Rheumatology • Irving, TX

medical director

Join to view full profile

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile

Already have an account?

  • Office

    1706N Britain Rd
    Irving, TX 75061

Summary

  • Board certified rheumatologist with >10 years experience in clinical trials/drug development, including successful BLA and MAA submissions to FDA and EMA, respectively.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Rheumatology, 2001 - 2004
  • U Texas SW Med Sch
    U Texas SW Med Sch2004
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1998

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1999 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • FACP American College of Physicians, 2011
  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, doub...  
    Gerd R Burmester, Yong Lin, Rahul Patel, Janet van Adelsberg, Erin K Mangan, Neil M H Graham, Hubert van Hoogstraten, Deborah Bauer, Juan Ignacio Vargas, Eun Bong Lee, Annals of the Rheumatic Diseases, 11/17/2016

Abstracts/Posters

  • Efficacy and Safety of Sarilumab Versus Adalimumab in a Phase 3, Randomized, Double-Blind, Monotherapy Study in Patients with Active Rheumatoid Arthritis with Intolera...
    Gerd Burmester, Yong Lin, Rahul Patel, Janet van Adelsberg, Erin Mangan, Hubert van Hoogstraten, Deborah Bauer, Juan Ignacio Vargas and Eun Bong Lee, American College of Rheumatology, Washington, DC, 11/16/2016

Professional Memberships

Other Languages

  • Spanish, Gujarati

External Links

Dr. Rahul Patel, Dr. Rahul Patel, MD, Dr. R Patel, Dr. Rahul K Patel